Experiment summary for ENCSR839UGR
doi:10.17989/ENCSR839UGR
Summary
- Status
- released
- Assay
- Mint-ChIP-seq
- Target
- H3K27me3
- Biosample summary
- Homo sapiens stimulated activated naive B cell female adult (39 years) treated with 1 μg/mL anti-CD40 for 72 hours, 100 ng/mL Interleukin-4 for 72 hours, 10 μg/mL anti-IgM for 72 hours
- Biosample Type
- primary cell
- Replication type
- unreplicated
- Treatments
- 1 μg/mL anti-CD40 for 72 hours, 100 ng/mL Interleukin-4 (UniProtKB:P05112) for 72 hours, 10 μg/mL anti-IgM for 72 hours
- Nucleic acid type
- DNA
- Platform
- Illumina NextSeq 500
- Controls
Attribution
ENCODE4 project
- Lab
- Bradley Bernstein, Broad
- Award
- UM1HG009390 (Bradley Bernstein, Broad)
- Project
- ENCODE
- External resources
- Aliases
- bradley-bernstein:Project Element 6915
- Date released
- March 28, 2022
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Antibody | Library |
|---|---|---|---|---|---|
| 1 | 1 | Homo sapiens female adult (39 years) stimulated activated naive B primary cell treated with 1 μg/mL anti-CD40 for 72 hours, 100 ng/mL Interleukin-4 for 72 hours, 10 μg/mL anti-IgM for 72 hours | ENCBS218KXX | ENCAB009VWX | ENCLB939GKA |
| 1 | 2 | Homo sapiens female adult (39 years) stimulated activated naive B primary cell treated with 1 μg/mL anti-CD40 for 72 hours, 100 ng/mL Interleukin-4 for 72 hours, 10 μg/mL anti-IgM for 72 hours | ENCBS218KXX | ENCAB009VWX | ENCLB299IQL |